Company: Clearside Biomedical Inc.
Job title: Director, Development
Dr. Leroy Muya serves as the Director of Development at Clearside Biomedical Inc. He earned his B.S. in Biochemistry from Indiana University of Pennsylvania in Indiana, PA and later, his PhD in Pharmaceutical Sciences from Mercer University in Atlanta, GA with a core aimed at the development of formulations and drug delivery systems for ophthalmic applications. His industry-based background spans custom-chemistries aimed at improving polymer surface properties, enhanced tear-film biochemistry on the ocular surface, as well as optimized drug targeting to specific ocular tissues during the development of innovative consumer products for ophthalmic use. In his current role at Clearside, Dr. Muya’s focus is on pre-clinical development, specifically, utilizing the suprachoroidal space as a platform and route of administration of small molecules and compounds of interest geared towards gene therapy for ophthalmic disorders.
Discovering Suprachoroidal Delivery as a Potential Platform to Deliver Gene Therapies to the Eye 12:00 pm
• Realizing the potential of suprachoroidal delivery to minimize impact on patients • Discussing recent data showing progress made using this technique so far • Exploring challenges associated with translating this technique from animals to humans for gene therapyRead more
day: Day One